Limba
Romanian
Romanian
English|
Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE), 1mg
6.475,98 RON
SKU
SKM_D4061_1mg
Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.
| Price | 5.442,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD. |
